HERANTIS PHARMA OYJ

Y-tunnus 2198665-7 · 4 myöntöä EU FTS -lähteistä

Yhteensä3 400 000 €

EU FTS3 400 000 €

Rahoitus vuosittain

Vuosi	Summa
2023	2 500 000 €
2016	900 000 €

190132320 - RETREATPD - REVOLUTIONARY THERAPEUTIC TREATMENT FOR STOPPING PROGRESSION OF PARKINSON'S DISEASEEuroopan komissio · Horizon Europe (X)
EU FTS · Helsinki-Uusimaa
2 125 000 € · 2023
190132320 - RETREATPD - REVOLUTIONARY THERAPEUTIC TREATMENT FOR STOPPING PROGRESSION OF PARKINSON'S DISEASEEuroopan komissio · Horizon Europe (X)
EU FTS · Helsinki-Uusimaa
375 000 € · 2023
732386 - TREATER - CLINICAL STUDY IN PARKINSON'S DISEASE WITH TWO UNIQUE GOALS: 1) PROOF-OF-CONCEPT OF CDNF PROTEIN FOR DISEASE MODIFICATION; 2) VALIDATION OF CLINICALLY TESTED DEVICE FOR INTRACEREBRAL DRUG DELIVERYEuroopan komissio · Horizon 2020 (RTD)
EU FTS · Helsinki-Uusimaa
869 855 € · 2016
732386 - TREATER - CLINICAL STUDY IN PARKINSON'S DISEASE WITH TWO UNIQUE GOALS: 1) PROOF-OF-CONCEPT OF CDNF PROTEIN FOR DISEASE MODIFICATION; 2) VALIDATION OF CLINICALLY TESTED DEVICE FOR INTRACEREBRAL DRUG DELIVERYEuroopan komissio · Horizon 2020 (RTD)
EU FTS · Helsinki-Uusimaa
30 145 € · 2016

Lähde: Euroopan komissio / Financial Transparency System